Altogether, these associations between the expression levels of tRNA‐Lys‐CUU and KARS1 in tumour tissues and prognosis of HCC patients indicate a potential clinical relevance for the interface of charging lysine with its tRNA in liver cancer. This evidence concerns the gene KARS1 and neoplasm.